Evidence map›Paper›PMID 32648211›Full record

ArticlePathology oncology research : POR2020

Low Fraction Size Re-irradiation for Large Volume Recurrence of Glial Tumours.

Ágnes Dobi, Barbara Darázs, Emese Fodor, Adrienne Cserháti, Zsófia Együd, Anikó Maráz, Szilvia László, Leopold Dodd, Zita Reisz, Pál Barzó and 2 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Ágnes DobiDepartment of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, H-6720, Hungary. dobiagnes@gmail.com.
Barbara DarázsDepartment of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, H-6720, Hungary.
Emese FodorDepartment of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, H-6720, Hungary.
Adrienne CserhátiDepartment of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, H-6720, Hungary.
Zsófia EgyüdDepartment of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, H-6720, Hungary.
Anikó MarázDepartment of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, H-6720, Hungary.
Szilvia LászlóDepartment of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, H-6720, Hungary.
Leopold DoddDepartment of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, H-6720, Hungary.
Zita ReiszDepartment of Pathology, University of Szeged, Állomás utca 1, Szeged, H-6725, Hungary.
Pál BarzóDepartment of Neurosurgery, University of Szeged, Semmelweis utca 6, Szeged, H-6725, Hungary.
Judit OláhDepartment of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, H-6720, Hungary.
Katalin HideghétyDepartment of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, H-6720, Hungary.
University of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to evaluate the efficacy of re-irradiation (re-RT) in patients with advanced local relapses of glial tumours and to define the factors influencing the result of the hyper-fractionated external beam therapy on progression after primary management. We have analysed the data of 55 patients with brain tumours (GBM: 28) on progression, who were re-irradiated between January 2007 and December 2018. The mean volume of the recurrent tumour was 118 cm

Indexed as

AdolescentAdultAgedBrain NeoplasmsChildFemaleFollow-Up StudiesGliomaHumansMaleMiddle AgedPrognosisRadiotherapy, ConformalRadiotherapy DosageRe-IrradiationRetrospective StudiesGliomaMultiform glioblastomaRe-irradiation

Identifiers

PMID32648211
PMCPMC7471107
OpenAlexW3041374890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.